Pub. Date : 2007 Apr 15
PMID : 17440073
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation. | Tetradecanoylphorbol Acetate | jun proto-oncogene | Mus musculus |
| 2 | SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation. | Tetradecanoylphorbol Acetate | jun proto-oncogene | Mus musculus |
| 3 | TPA-mediated SAG induction was significantly reduced in JB6-Cl.41 cells overexpressing a dominant-negative c-Jun, indicating a requirement of c-Jun/AP-1. | Tetradecanoylphorbol Acetate | jun proto-oncogene | Mus musculus |
| 4 | TPA-mediated SAG induction was significantly reduced in JB6-Cl.41 cells overexpressing a dominant-negative c-Jun, indicating a requirement of c-Jun/AP-1. | Tetradecanoylphorbol Acetate | jun proto-oncogene | Mus musculus |
| 5 | TPA-mediated SAG induction was significantly reduced in JB6-Cl.41 cells overexpressing a dominant-negative c-Jun, indicating a requirement of c-Jun/AP-1. | Tetradecanoylphorbol Acetate | jun proto-oncogene | Mus musculus |
| 6 | When overexpressed, SAG remarkably reduced both basal and TPA-induced c-Jun levels, whereas SAG small interfering RNA (siRNA) silencing increased substantially the levels of both basal and TPA-induced c-Jun. | Tetradecanoylphorbol Acetate | jun proto-oncogene | Mus musculus |
| 7 | When overexpressed, SAG remarkably reduced both basal and TPA-induced c-Jun levels, whereas SAG small interfering RNA (siRNA) silencing increased substantially the levels of both basal and TPA-induced c-Jun. | Tetradecanoylphorbol Acetate | jun proto-oncogene | Mus musculus |